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Background: Surgery induces insulin resistance that might be alleviated by a nutritional drink given preoperatively.
The authors hypothesized that some of the beneficial effects of the drink could be attributed to the volume
component (approximately 1 L) rather than to the nutrients.
Methods: Sixty patients scheduled for elective total hip replacement under spinal anesthesia were recruited to a
clinical trial, and randomly allocated to preoperative fasting, to oral ingestion of tap water, or to oral ingestion of a
carbohydrate drink. An intravenous glucose tolerance test calculated glucose clearance and insulin sensitivity on the
day before surgery, in the postoperative ward, and on the day after surgery. Other parameters were stress (cortisol
in plasma and urine), muscle catabolism (urinary 3-methylhistidine), and wellbeing.
Results: Fifty-seven patients completed the study. In the postoperative ward, the glucose clearance and the insulin
response had decreased from the previous day by 23% and 36%, respectively. Insulin sensitivity did not decrease
until the next morning (−48%) and was due to an increased insulin response (+51%). Cortisol excretion was highest
on the day of surgery, while 3-methylhistidine increased 1 day later. Follow-up on the third postoperative day
showed an average of 1.5 complications per patient. Wellbeing was better 2 weeks after than before the surgery.
None of the measured parameters differed significantly between the study groups.
Conclusions: Preoperative ingestion of tap water or a nutritional drink had no statistically significant effect on
glucose clearance, insulin sensitivity, postoperative complications, or wellbeing in patients undergoing elective hip
surgery.
Trial registration: Registration number: NCT 01211184 (http://www.clinicaltrials.gov)
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indexBackground
Elective hip replacement, which is a very common oper-
ation performed worldwide, involves a convalescence
period of many weeks [1]. The surgery creates a cascade
of reactions in the body, including insulin resistance [2],
stress hormone secretion, and, possibly, an imbalance in
body fluid composition. These effects, in turn, create
physical reactions, including degradation of muscle [3,4].
Postoperative insulin resistance has been linked to nau-
sea and vomiting [5], and to impairment of wellbeing [6]* Correspondence: r.hahn@telia.com
1Research Unit, Södertälje Hospital, House 18, 581 85 Södertälje, Sweden
3Section for Anesthesia, Faculty of Health Sciences, Linköping University,
Linköping, Sweden
Full list of author information is available at the end of the article
© 2012 Ljunggren and Hahn; licensee BioMed
Creative Commons Attribution License (http:/
distribution, and reproduction in any mediumbut it can be limited or prevented by insulin [7], preopera-
tive infusion [8,9], or oral administration [10] of glucose.
A nutritional carbohydrate drink given before surgery [11]
might also prevent insulin resistance. However, whether
the drink affects postoperative catabolism is unknown, al-
though insulin resistance has been correlated with catabol-
ism and intracellular dehydration after hysterectomy [12].
The benefit of a nutritional drink with regard to overall
postoperative wellbeing is still uncertain [13].
The hypothesis of the present study was that some
beneficial effects of a nutritional drink after elective hip
replacement surgery could be attributed to the volume
component of the drink. The research, therefore,
assessed the relationship between fluid intake, with and
without carbohydrates, on metabolism (glucoseCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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ism), body fluid volumes, surgical complications, and
postoperative wellbeing. A recently validated glucose tol-
erance test assessed insulin sensitivity [14].Methods
Patients
Between May 2008 and September 2009, 60 patients be-
tween 44 and 89 years of age (mean age, 69 years)
undergoing elective total hip replacement under spinal
anesthesia were studied in an open randomized clinical
trial. Total hip replacement surgery implies that both
the acetabular cup and the femoral head are replaced.
The cup is usually made of plastic while the head is of
metal. The components can be either cemented or just
pressed firmly against the bone. Total hip replacement
surgery was chosen for the study because the surgical
procedure is well standardized and intake of a carbohy-
drate drink is not yet a routine, which is recommended
before abdominal surgery [15].
Exclusion criteria were endocrinologic disorders, in-
cluding diabetes, and treatment with cortisone. The Re-
gional Ethics Committee of Stockholm (Ref. 2007/1628-
31/4) approved the protocol. Each patient gave his/her
informed consent to participate. The most common dis-
eases affecting the patients included hypertension
(n= 17), previous thrombosis (n= 4), chronic obstructive
pulmonary disease (n= 3), and previous cardiovascular
surgery (n= 3).Procedure
Each patient was randomly assigned to one of three
study groups by the sealed envelope method after all
baseline parameters had been measured in the orthope-
dics department on the day before the surgery. Before
the study started, the surgeon (SL) prepared 60 blank
envelopes in which the treatment group in the propor-
tion 1:1:1 was written on a piece of blank paper. The re-
search nurse drew the envelopes which were mixedFigure 1 Flow chart showing the measurements taken in relation to ttogether in a large bucket and opened each of them to-
gether with the patient. The groups were:
1. Fasting: no food or water from midnight before the
surgery (control)
2. Tap water: 800 mL by mouth, 2 h before entering
the operating room
3. Nutrition: a carbohydrate drink (50 kcal/100 mL;
PreopR, NutriciaNordica AB, Stockholm, Sweden)
800 mL in the evening before the surgery (Day 0)
and 400 mL 2 h before entering the operating room
(Day 1)
Cemented total hip replacements were performed
under spinal anesthesia (cement was avoided in three
middle-aged patients). Patient monitoring consisted of
pulse oximetry and non-invasive blood pressure and
heart rate measurement. At the end of surgery, patients
with more than minimal bleeding were given 1 g of tran-
examic acid intravenously (Cyklokapron, Meda AB,
Solna, Sweden).
Postoperative pain was managed using an epidural
catheter with a continuous infusion of levobupivacaine
and sufentanil (n= 22) or a wound catheter with ropiva-
caine and ketorolac (n= 25; the hospital practice chan-
ged during the study period). All patients were also
given oral paracetamol. Oral oxycodone served as the
rescue pain reliever.
Physiological measurements
Figure 1 shows the scheme used for these measurements.
Intravenous glucose tolerance test (IVGTT)
A short IVGTT was performed in the fasting state on
Day 0, 2 to 3 h after surgery on Day 1, and before break-
fast on Day 2. A bolus of 0.2 g/kg of glucose was
injected as a 30% solution over 4 min, and the plasma
glucose and insulin concentrations were measured at
baseline and at 10, 20, 30, 45, 60, and 75 min. Plasma
glucose was measured on a Modular P (Rochehe surgery.
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Roche-Hitachi Modular E170 (Hitachi, Tokyo, Japan).
Physical stress
The serum cortisol concentration was measured 2 to 3 h
after the surgery ended; it was analyzed on the Roche-
Hitachi Modular E170. The free cortisol fraction over
time was estimated from the ratio of the cortisol and
creatinine concentrations in the urine collected from a
urinary bladder catheter inserted just before the oper-
ation started and up to the morning of Day 2. A second
urinary collection began on the morning of Day 2 and
ended on the morning of Day 3. The method used for
the cortisol analysis was liquid chromatography tandem-
mass spectrometry [16,17].
Muscle catabolism
The breakdown of muscular protein was quantified in the
urine collected on Day 2 and Day 3 by measuring the ratio
of 3-methylhistidine (3-MH) to creatinine, using a Bio-
chrom 30 amino acid analyzer (Biochrom Ltd., Cambridge,
UK) [18,19]. All patients were served lactovegetarian food
from the day before surgery (Day 0) and throughout their
hospital stay to prevent the confounding effects of exogen-
ous meat on the excretion of 3-MH.
Body fluid volumes
Bioelectrical impedance analysis using a Xitron 4000B
Spectrum Analyzer (Xitron Technologies Inc., San
Diego, CA, USA) estimated the extracellular, intracellu-
lar, and total body fluid volumes (ECF, ICF, and TBW,
respectively) [20,21]. Each value was the mean of three
successive recordings based on the preoperative body
weight.
Complications
Three approaches were used to collect data on compli-
cations. The hand-written medical records from the
perioperative period and postoperative ward were used
to calculate the mean systolic pressure and also to count
the number of postoperative hypotensive events, defined
as systolic arterial pressure <80 mmHg.
In the second approach, a research nurse used a
checklist of 18 complications based on two published
schemes [22,23] to register all postoperative adverse
events up to Day 3. Finally, an orthopedic surgeon
blinded to the randomization listed the complications
during the entire hospital stay as noted by the hospital
staff in the digital medical records.
Calculations
Glucose kinetics
The kinetics of the glucose infused during the IVGTT
was analyzed to characterize how effectively the studyparticipants handled the exogenous glucose. In a one-
compartment turnover model, the plasma concentration
of glucose above baseline (C) at any time (t) resulting








 C tð Þ
in which Vd is the volume of distribution and CL the
clearance of glucose.
The best estimates and the associated standard devia-
tions for the unknown parameters Vd and CL in this
equation were estimated for each experiment individu-
ally by applying a non-linear least-squares regression
routine, based on the Gauss-Newton method, to the
analytical solution of the differential equation until no
parameter changed by more than 0.1% in each iteration.
Matlab version 4.2 (Math Works Inc., Natick, MA,
USA) was used. The half-life (T1/2) was calculated as
ln 2 . Vd /CL.
Insulin sensitivity
The glucose kinetic parameters and the area under the
curve indicating plasma insulin (AUCins) above baseline
during the IVGTT were used to estimate insulin sensitivity:





The result was expressed as the Mbw of a hyperinsuli-
nemic glucose clamp, to which the present approach
was compared in non-diabetic volunteers with r = 0.80
and a 25th-75th prediction error of ±10% [14]. The same
relationship has been previously evaluated as an index of
insulin sensitivity from short IVGTTs in 496 diabetic
and non-diabetic patients [24].
Insulin sensitivity was also assessed with the ‘Quicki’
method [25], which uses the plasma glucose and insulin
concentrations at baseline:
0Quicki0 ¼ 1ð10log Pglucose þ 10log PinsulinÞ
In the equation, the symbols denote the 10-logarithm of
the P-glucose (i.e. the plasma glucose) and plasma insulin
concentrations.
Wellbeing
Four scales previously used and validated in healthcare
assessed life quality. The patient filled in these forms in
the afternoon on the day before surgery. A research
nurse interviewed the patients and filled in the forms
once more 2 weeks after the surgery. The health index
(HI) was also applied on the second postoperative day.
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items designed to acquire information about different
aspects of psychological wellbeing [26,27]. The scale mea-
sures ‘energy’ and negative and positive wellbeing with four
statements for each; the patient can respond using one of
four levels. Higher values denote better general wellbeing.
Health index (HI) is a Swedish questionnaire in which
the patient responds to 10 questions about ‘energy’, tem-
per, mood, fatigue, loneliness, sleep, vertigo, bowel func-
tion, pain, mobility, and overall health during the past
week [28]. When applied on the day after surgery, the
questions pertain to the situation during the past 12 h.
Answers can be given on four levels in which: 1 = very
poor; 2 = rather poor; 3 = rather good; and 4 = very good.
Hence, the highest total HI score for a patient is 40 and
the lowest is 10. The test has been used to study self-
perceived health status after ileal conduit urinary diver-
sion [28] and after laparoscopic cholecystectomy [29].
Chalder’s Fatigue Scale (FQ) consists of 14 questions,
which cover both physical and mental aspects of fatigue
[30]. A ‘yes’ answer to a question about fatigue is graded
as 1 and a ‘no’ answer as 2. Uncertain answers were
graded as 1.5. The scale has been used to study fatigueFigure 2 CONSORT diagram for the trial.in cancer [30] but also in other fields, such as in popula-
tion surveys [31]. Translation from English to Swedish
was checked through back-translation. The wording was
virtually identical except in one question where ‘sleepy
or drowsy’ was back-translated to ‘tired or lethargic’.
EQ-VAS is a ruler for rating self-perceived health; it is
the last item of the EQ-5D [32].
Statistics
The study was powered to detect a difference in the CL
for glucose of 30% between any of the study groups and
the control with a certainty of 90%. Reference data were
obtained from both the preoperative and postoperative
studies. In non-diabetic healthy humans CL has been
0.72 (mean, SD 0.18) [33] and 0.60 (0.26) [14]. During
laparoscopy CL has been 0.21 (0.05) [34] and on the sec-
ond postoperative day in hysterectomy patients 0.42
(0.08) [12]. The mean of these values yields a standar-
dized difference of 1.05 which was entered into a nomo-
gram showing that 18 patients per group were required
[35]. The ability of the study to detect postoperative dif-
ferences would be better than preoperative ones due to
less expected scattering of those data.
Table 1 Baseline characteristics of the patients and the
operations
Parameter Fasting Water Nutrition
(n=20) (n=18) (n=19)
Age (years) 68.5 (9.6) 66.4 (10.6) 65.2 (8.0)
Body weight (kg) 82.5 (20.0) 82.6 (10.8) 83.1 (13.8)
ASA class I/II/III (%) 16/63/21 6/69/25 24/63/13
Operating time (min) 115 (27) 103 (20) 99 (21)
Blood loss (mL) 450 (350–500) 400 (300–450) 400 (238–700)
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were evaluated with variance of analysis (ANOVA).
When there was a skewed distribution, the data were
expressed as the median (25th-75th percentile range),
and the differences studied with the Kruskal-Wallis test.
Changes during the study were evaluated with the Wil-
coxon matched-pair test. Incidence data were studied
with the chi-square test. Cronbach’s alpha coefficient
was used to test the reliability of the tests of wellbeing.
P <0.05 was considered statistically significant.Intravenous fluid (mL)
Acetated Ringer’s 1000 (0) 1000 (0) 1000 (0)







Tranexamic acid (%) 50 56 26
Blood Hb
Before surgery (g/dL) 13.32 (1.15) 13.53 (1.04) 13.56 (1.40)Results
Sixty patients were randomly chosen and 57 completed
the study (three dropped out due to personal reasons).
Thirty of 171 insulin AUCs had to be discarded due to
occasional hemolysis (Figure 2).
Data on the course of the surgery did not differ signifi-
cantly between the study groups (Table 1). Overall, the
operations lasted for an average of 106 (23) min and the
average blood loss amounted to 400 (300–600) mL.Morning of Day 2 (g/dL) 10.33 (1.26) 9.72 (1.73) 10.41 (1.85)
Erythrocyte transfusion
Frequency (%) 30 44 42
Units given (mean) 1.8 2.8 2.4
Body weight change
Day 0 to Day 2 (%)b
+0.4 (2.3) +1.9 (2.7) +0.3 (1.7)
aHydroxyethyl starch 130/0.4 (Voluven, Fresenius-Kabi).
bOnly 12, 12, and 10 patients were weighed in each group on Day 3 as the
others were unable to stand up on the scale.
Day 0, the day before surgery; Day 1, day of surgery; Day 2, first postoperative
day; Day 3, second postoperative day.Glucose and insulin
The baseline concentrations of plasma glucose and insu-
lin before surgery were virtually identical in the three
study groups, the pooled data being 5.0 (0.6) mmol/L
and 39 (26–71) pmol/L, respectively. Plasma glucose at
baseline was 16% higher on Day 1 and a further 10%
higher on Day 2 (both P <0.001). The participants’ base-
line insulin was unchanged, except for an increase
observed in the Nutrition group, on Day 2 (P <0.01).Glucose kinetics
The mean plasma glucose during the IVGTTs on the
three consecutive days was 8.3 (1.0), 9.7 (1.5), and 9.9
(1.3) mmol/L, respectively (Figure 3).
CL was reduced by 23% (Day 1) and 11% (Day 2), with
no significant differences between the groups. T1/2
increased by 60% (Day 1) and 35% (Day 2; Table 2).Insulin
The mean plasma insulin concentration during the
IVGTT decreased slightly in the postoperative ward
(P <0.03), but then rose by 18% on Day 2 (P <0.001;
Figure 4). The AUC changed by −36% (Day 1) and +51%
(Day 2) as compared to the preoperative value (both
P <0.001). The same pattern appeared in all three groups.
The insulin sensitivity on Day 0 (expressed as Mbw)
was 31 (19–41) μmol/kg/min when derived from the
IVGTT. Mbw showed no statistically significant change
from Day 0 to Day 1 but decreased on Day 2 (P <0.001).
The decrease was much greater when based on the
IVGTT (−48%) compared to ‘Quicki’ (−8%; Table 2).Physical stress, catabolism, and body fluid volumes
Plasma cortisol in the postoperative ward was 359 (182–
601) nmol/L; no statistically significant differences were
observed between the groups. Urine cortisol decreased
by 26% between Day 1 and Day 2 (P <0.005; Table 3).
Muscle catabolism, as indicated by the urinary 3-
MH/creatinine ratio, did not differ significantly between
the groups. The participants’ overall excretion decreased
by 7% from Day 1 to Day 2 (P <0.015; Table 3).
The average ECF volume was unchanged by the sur-
gery. The ICF volume increased by 4% on Day 1 and 3%
on Day 2 (not significant, Table 3).Complications
No statistically significant differences were observed be-
tween the study groups with respect to peri- and post-
operative hemodynamics.
The nurse’s follow-up showed that a mean of 1.5 compli-
cations occurred per patient by Day 3. Pain, nausea, and
hypotension were most common (Table 4). Pain scores
were virtually identical in those who received a local
Figure 3 The plasma glucose concentrations during the intravenous glucose tolerance tests (IVGTT). Data are from Day 0 (top row), Day
1 (middle row), and Day 2 (bottom row) in the Fasting, Water, and Nutrition groups, respectively. Each thin line is one IVGTT test. The thick lines
are the modeled curves based on the mean values for Vd and CL per each group and occasion.
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shown).
Only a mean of 0.3 complications per patient was
recorded in the digital journal.Figure 4 The plasma insulin concentrations (median) during the IVGT
Nutrition groups, respectively.The median hospital stay was one day shorter in the
Nutrition group (5 days) than in the other two groups
(6 days) but the difference was not statistically signifi-
cant (P = 0.36).T. Data are from Day 0, Day 1, and Day 2 in the Fasting, Water, and
Table 2 Changes in glucose kinetics and insulin
sensitivity from before surgery up to the second
postoperative day
Parameter Fasting Water Nutrition
Glucose dose (g) 17.2 (3.8) 17.4 (2.5) 17.2 (3.0)
Plasma glucose at
baseline, change (%)
Day 0 to Day 1 +12 (22) +20 (20) +16 (17)
Day 0 to Day 2 +25 (15) +28 (17) +30 (13)
Mean glucose
during IVGTT (%)
Day 0 to Day 1 +14 (18) +21 (18) +19 (15)




Day 0 to Day 1 +10 (22) +12 (25) +7 (24)
Day 0 to Day 2 0 (4) +5 (19) +6 (22)
Clearance, change (%)
Day 0 to Day 1 −23 (22) −23 (28) −23 (30)
Day 0 to Day 2 −14 (37) −11 (37) −9 (46)
Half-life, T1/2,
change (%)
Day 0 to Day 1 +57 (62) +69 (84) +59 (79)






























‘Quicki’ Day 0 to Day 1 +2 (19) +2 (8) −5 (15)
Day 0 to Day 2 −5 (16) −5 (14) −15 (16)
a18% of the insulin AUC data are missing due to hemolysis.
Data are the mean (SD) or the median (25th-75th percentile range).
Day 0, the day before surgery; Day 1, day of surgery; Day 2, first postoperative
day; Day 3, second postoperative day.
Table 3 Physical stress, catabolism, and changes in body
fluid volume indices
Parameter Fasting Water Nutrition
Physical stress
Serum cortisol (nmol/L)
Day 1 447 (161–620) 253 (118–544) 376 (222–553)
Urine cortisol/creatinine
Day 1 to Day 2 40 (15–99) 41 (18–54) 41 (27–54)




Day 1 to Day 2 18.0 (2.0) 17.3 (2.6) 17.5 (2.7)
Day 2 to Day 3 19.3 (2.8) 18.1 (2.7) 18.6 (3.1)
Body fluid volumes
ECF volume change (%)
Day 0 to Day 2 −1 (4) 0 (6) −2 (5)
Day 0 to Day 3 0 (6) +1 (6) −2 (6)
ICF volume change (%)
Day 0-Day 2 +9 (22) −2 (10) +6 (11)
Day 0-Day 3 −1 (10) +3 (23) +8 (22)
TBW volume change (%)
Day 0 to Day 2 +3 (8) −1 (5) +2 (5)
Day 0 to Day 3 −1 (5) +2 (10) +2 (9)
Data are the mean (SD) or the median (25th-75th percentiles) depending on
the distribution.
ECF, extracellular; ICF, intracellular; TBW, total body water.
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W-BQ12 scores on general well-being increased after
the surgery, from 27 (20–29) to 31 (25–33) points
(P <0.0001) with no difference between the groups
(Figure 5A, B).
The total HI score changed from 29 (24–32) before sur-
gery to 26 (23–29; P <0.005) postoperatively, while it
increased to 31 (29–34) 2 weeks later (P <0.001,Figure 5C). Two weeks postoperatively, HI was lower in the
Water group compared to the Nutrition group (P <0.02).
The total FQ score changed from 23 (20–27) to 26
(24–27; P <0.001) with no difference between the
groups (Figure 5 D, E).
The EQ-VAS score changed from 60 (40–70) before
surgery to 75 (63–80) 2 weeks later (P <0.001) with no
difference between the groups (Figure 5F).
The Cronbach’s alpha coefficients for the responses to
the W-BQ12, HI, and FQ tests before surgery were 0.80
(mean of the three parts), 0.85, and 0.87, respectively.
Two weeks after surgery, the corresponding values were
lower: 0.72, 0.71, and 0.71.
Discussion
Ingestion of a carbohydrate drink before surgery is
believed to improve postoperative wellbeing by preventing
the trauma-induced impairment of the glucose metabol-
ism [10,11,36-38]. The present study was undertaken to
examine whether these effects could at least partly be
explained by the fact that the nutritional drink contains a
large amount of water (1.2 L). This question was to be
answered by studying if the results in the Water group
Table 4 Hemodynamic stability, complications, and
length of hospital stay
Parameter Fasting Water Nutrition
Systolic blood pressure, % of baseline (mean, SD)
Baseline (mmHg) 155 (14) 149 (20) 158 (19)
Lowest during spinal anesthesia (%) 65 (19) 68 (12) 67 (13)
During surgery (%) 72 (17) 75 (10) 76 (7)
Postoperative ward (%) 70 (6) 68 (11) 66 (8)
Postoperative hypotension (%)a 30 50 32
Nurse’s follow-upb
All ( mean per patient) 1.35 1.66 1.63
Pain 0.50 0.61 0.42
Nausea and vomiting 0.30 0.28 0.32
Hypotension 0.25 0.44 0.42
Food intolerance 0.10 0.11 0.11
0-1 complication (n) 12 9 10
≥ 2 complications (n) 8 9 9
All complications in digital journal
(mean per patient)
0.30 0.39 0.21
Hospital stay (days) 6 (5–7) 6 (5–7) 5 (5–6)
aDrop in arterial systolic pressure to <80 mmHg.
bErythrocyte transfusions are not included here but reported in Table 1.
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in the Nutrition group. To our surprise, neither preopera-
tive intake of tap water nor the nutritional drink did affect
glucose kinetics, insulin sensitivity, hemodynamics, com-
plications, hospital time, or wellbeing after elective hip re-
placement surgery. The study was powered to detect a
difference in glucose clearance but some other parameters,
such as insulin sensitivity and wellbeing, would probably
need larger study groups to arrive at safe conclusions.
However, the lack of even trends towards benefits for the
interventions is striking.
There are reasons to believe that either tap water or
nutrition should promote better-off patients. Hypovol-
emia is apparently common in the preoperative setting
[39]; therefore, volume optimization should reduce the
incidence of postoperative complications [40]. Those
who received water were allowed 2 h to excrete excess
fluid; doctors then assumed that the patients were well
hydrated and that they were more likely to have a more
normal blood volume when surgery started. However, no
benefit from oral water over the fasting state was found.
Researchers have previously proposed that replacing
preoperative fasting with caloric intake modified the
metabolic response to surgery. The nutritional drink
preparation, which loads the liver with carbohydrates,
has been shown to preserve insulin sensitivity after colo-
rectal [36] and hip surgery [37] but not after cardiac sur-
gery [41]. Moreover, researchers have claimed thatcarbohydrate drinks improve wellbeing and reduce nau-
sea and vomiting [8,9,38] although these results have not
been consistent [13,42]; this study could not confirm the
claim. Our results showed that preoperative fasting and
the nutritional drink were followed by the same degree
of urinary cortisol excretion, muscle catabolism, and
length of hospital stay.
The present study adds to our knowledge about the time
course of the development of postoperative insulin resist-
ance. Hyperglycemia developed within hours after the sur-
gery, but it was matched by the inhibition of the insulin
response to glucose. Insulin resistance did not develop
until the next day, and was then associated with a boosted
insulin response to glucose. This sequence of events
agrees with that of adolescents who develop type 2 dia-
betes [43]. Another observation is that high cortisol excre-
tion preceded an increase in muscle catabolism by 1 day.
Insulin sensitivity was quantified with an IVGTT
[14,24], which, in contrast to the hyperinsulinemic glu-
cose clamp, provides information about the intrinsic in-
sulin response. The IVGTT induces a smaller insult to
normal physiology than the clamp, and therefore, lends
itself to repetition during the postoperative follow-up.
Insulin sensitivity was also assessed with the ‘Quicki’
equation, which, just like the older HOMA test, uses the
baseline values of plasma glucose and insulin. These
simple tests are intended for population studies but have
also been applied after surgery [38,41]. The baseline
values were much less affected by the surgery (−8%)
compared to the glucose tolerance test (−48%), which
provided results more in accordance with those of the
hyperinsulinemic clamp [10,37].
The scales describing perceived health and wellbeing
yielded higher values than before the operation as little
as 2 weeks after hip replacement surgery. The difference
ranged between 7% and 30%. The W-BQ12 and FQ
scales support that the improvements can be attributed
to several aspects of wellbeing, such as perceived ‘en-
ergy’ and both mental and physical health. As expected,
a dip in the HI score occurred 2 days after the surgery,
but for ethical reasons, not all protocols for evaluating
wellbeing were used in the early postoperative period.
The scales selected for the study ask questions pertinent
to early convalescence. Several scales were used to obtain
as complete view of the postoperative wellbeing as pos-
sible. Previous studies of health after total hip replacement
have focused on the outcome of the implant, and there-
fore, used a follow-up period of 3 to 12 months [44,45].
They confirmed that the surgery improved both physical
and mental aspects of wellbeing [46]. EQ-VAS applied be-
fore, and 1 year after the surgery, yielded almost identical
values as those reported here after only 2 weeks. This sug-
gests that most or all of the improvement in wellbeing
occurs early after the hip replacement surgery.
Figure 5 Wellbeing and life quality shortly after elective total hip replacement surgery. Bars = median values; Error bars = 25th and 75th
percentiles.
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preserve insulin sensitivity is a key argument for recom-
mending its use before surgery [15]. This evidence stems
from two small studies. Insulin sensitivity was better
maintained in six patients who were given the carbohy-
drate drink before colorectal operations compared to
seven patients who were in the fasting state [36]. The
conclusion is valid only by assuming a linear relationship
between insulin resistance and the operating time, which
was not found in the present study (data not shown).
The same carbohydrate drink preserved insulin sensi-
tivity to a higher degree in eight patients than in another
seven who received the placebo drink before elective hip
surgery. However, the latter group was younger and had
22% higher insulin sensitivity at baseline [37]. A third
reference on this topic provides a duplicate report sum-
marizing the findings of the first two [10]. Other authors
have investigated this issue by using the HOMA test;
these investigations both support [38] and refute [41]
the hypothesis.
The present study has several limitations. The trial
was non-blinded as blinding was considered difficult tocarry out in the fasting group. The difference in volumes
of fluid administered 2 h before the surgery was due to
the differences in volumes of distribution between tap
water (TBW) and a carbohydrate drink (ECF volume)
[12]. The Fasting group received 10% more colloid fluid
during the surgery than the other two groups, but they
also bled 13% more. The study layout was based on the
assumption that the nutritional drink would preserve in-
sulin sensitivity and reduce the incidence of complica-
tions, whereby focus was on postoperative comparisons
between the groups. This fact explains why cortisol and
3-MH were not measured preoperatively.
Another limitation was that insulin sensitivity was not
measured with the clamp technique, which is the golden
standard method, although intravenous glucose toler-
ance is a widely accepted alternative [47]. The relatively
sparse sampling scheme, motivated by ethical considera-
tions of maximum blood sampling volume, has recently
been validated against the hyperglycemic glucose clamp
[14,24]. However, hemolysis in some insulin samples
made the reported values too uncertain to be included
in calculations of the AUC. Therefore, 18% of the AUCs
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sensitivity being based on fewer data than originally
intended.
Conclusions
This randomized controlled trial shows that neither the
preoperative intake of tap water nor a nutritional drink
alleviates the reduction of the glucose clearance that
occurs after elective hip replacement surgery. Moreover,
there was no evidence that these treatments affected in-
sulin sensitivity, hemodynamics, the incidence of post-
operative complications, or wellbeing.
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